Amarin Corp Plcuk (AMRN) Gross Profit Growth (5y) (2018 - 2026)

Amarin Corp Plcuk (AMRN) Gross Profit Growth (5y) (2018 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -31.03%
Dec 31, 2025 -29.44%
Sep 30, 2025 -29.04%
Jun 30, 2025 -13.91%
Mar 31, 2025 -26.87%
Dec 31, 2024 -15.83%
Sep 30, 2024 -28.48%
Jun 30, 2024 -11.33%
Mar 31, 2024 -10.69%
Dec 31, 2023 -5.48%
Sep 30, 2023 -6.52%
Jun 30, 2023 1.40%
Mar 31, 2023 7.57%
Dec 31, 2022 9.48%
Sep 30, 2022 12.14%
Jun 30, 2022 5.21%
Mar 31, 2022 22.32%
Dec 31, 2021 31.88%
Sep 30, 2021 35.72%
Jun 30, 2021 38.22%